Acute coronary syndrome Trials in Cambridge, Canada
Conditions / Acute coronary syndrome / Cambridge, Canada
Acute coronary syndrome has been the subject of sustained clinical investigation across multiple research sites.
11 total trials for this combination
Showing top 10 of 11 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT00391872 | A Comparison of Ticagrelor (AZD6140) and Clopidogrel in Patients With Acute Coronary Syndrome | COMPLETED | PHASE3 |
| NCT00831441 | Phase III Acute Coronary Syndrome | TERMINATED | PHASE3 |
| NCT00699998 | A Comparison of Prasugrel and Clopidogrel in Acute Coronary Syndrome Subjects | COMPLETED | PHASE3 |
| NCT01147250 | Evaluation of Cardiovascular Outcomes in Patients With Type 2 Diabetes After Acute Coronary Syndrome During Treatment With AVE0010 (Lixisenatide) | COMPLETED | PHASE3 |
| NCT02525939 | Effect of Dalcetrapib vs Placebo on CV Risk in a Genetically Defined Population With a Recent ACS | COMPLETED | PHASE3 |
| NCT05754957 | A Study of Milvexian in Participants After a Recent Acute Coronary Syndrome | ACTIVE_NOT_RECRUITING | PHASE3 |
| NCT05918861 | Effect of Dalcetrapib on CV Risk in a Genetically Defined Population With a Recent ACS | RECRUITING | PHASE3 |
| NCT01000727 | The Stabilization Of pLaques usIng Darapladib-Thrombolysis In Myocardial Infarction 52 Trial | COMPLETED | PHASE3 |
| NCT00557921 | Clopidogrel and the Optimization of Gastrointestinal Events (COGENT-1) | TERMINATED | PHASE3 |
| NCT00968708 | Cardiovascular Outcomes Study of Alogliptin in Patients With Type 2 Diabetes and Acute Coronary Syndrome | COMPLETED | PHASE3 |